MedTrace Logo

Gabapentin for Perioperative Pain Relief in Surgical Abortion

NCT04292171 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2020-12-02

Study results available
· View outcomes & findings →

Summary

Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.

Conditions

  • Pain Control

Interventions

DRUG

Gabapentin

Preoperative treatment with Gabapentin

DRUG

Placebos

Preoperative treatment with Placebo

Sponsors & Collaborators

  • University of Nevada, Las Vegas

    lead OTHER

Principal Investigators

  • Vani Dandolu, MD · University of Nevada School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-03-30
Completion
2018-03-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04292171 on ClinicalTrials.gov